SUBSCRIBE
SUBSCRIBE

Nexus Pharmaceuticals, Inc.

IN THE PRESS
Business
Nexus Pharmaceuticals Celebrates Grand Opening of New, State-of-the-Art Manufacturing Facility
July 19, 2021
 · 
3 min read
Nexus Pharmaceuticals Makes Key Investment to Help COVID-19 Vaccine Effort
April 14, 2021
 · 
2 min read
BioMidwest
Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP
April 12, 2021
 · 
3 min read
FDA
Nexus Pharmaceuticals Receives FDA Approval for Potassium Chloride in Water for Injection
March 25, 2021
 · 
1 min read
BioMidwest
Nexus Pharmaceuticals Announces Verbal to Occupy Authorization
March 23, 2021
 · 
2 min read
BioMidwest
Nexus Pharmaceuticals Stands Ready to Support Efforts to Increase Vaccine Manufacturing
February 11, 2021
 · 
2 min read
BioMidwest
Nexus Pharmaceuticals Announces Diversity Certification
December 3, 2020
 · 
1 min read
FDA
Nexus Pharmaceuticals Receives FDA Approval for Succinylcholine Chloride Injection, USP
October 29, 2020
 · 
1 min read
BioMidwest
Nexus Pharmaceuticals, Inc. Announces Launch of Emerphed™ (ephedrine sulfate) RTU Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)
June 26, 2020
 · 
2 min read
FDA
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)
April 21, 2020
 · 
2 min read
Load More
AWARDS
  • 2023 Best Places to Work
JOBS